Genway Biotech, LLC

Aviva Systems Biology Corporation Part of Aviva Systems Biology Corporation

UEI
Q7KGV5SPMHU6
CAGE
3DV35
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date
Website
genwaybio.com
Founded
1998
Employees
11-50
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Latest 5 listed here. See the rest on GovTribe.

SBA capabilities narrative

We use gene-specific antibodies to discover and validate important proteins: drug targets, disease biomarkers, therapeutic proteins and antibodies. We offer a wide range of antibody, protein, antigen and other biological products and services.

Quick answers

Is Genway Biotech, LLC registered in SAM.gov?

Genway Biotech, LLC's SAM.gov registration expired on July 31, 2026.

What is Genway Biotech, LLC's most recent federal award?

Genway Biotech, LLC's most recent federal contract award is Human varicella zoster IGG elisa assay k - vaccines (HT001418P0244), from Defense Health Agency, on May 29, 2018.

On GovTribe

See Genway Biotech, LLC's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors